Tag: stock market analysis
Why Investors Should Watch AbbVie Inc (ABBV)
AbbVie Inc is a global biopharmaceutical company that specializes in the discovery, development, manufacturing, and marketing of advanced medicines.
AbbVie focuses primarily on immunology, oncology, neuroscience, and virology treatments, and...
NASDAQ Remains Strong; Should Investors Buy The Dip?
In a recent analysis of the current stock market, I stated:
“But, unless the market continues to broaden, we can almost take the Mag 7...
How Climate Change Risks Could Impact Investments in 2025
This year is on track to be the warmest on record. Extreme weather that accompanies a warming planet has also become the new norm,...
S&P 500 Index Update: Sideways Price Consolidation Unfolding?
The S&P 500 has shown a loss of upside momentum with its last rally higher off the early November low.
There is still no sign...
Is the Nasdaq Rally For Real? Watch for Market Broadening!
While the Nasdaq 100 made new all-time highs today climbing over 20,000, all the Magnificent 7 stocks and investors cheered!
And as they should. After...
How Will Stock Market Perform Under Trump?
As we embark on a four-year journey with President Trump at the helm of the world’s largest economy, there are both knowns and unknowns.
Given...
Why Biotech Sector ETF (IBB) May Turn Bullish In 2025
One of the big themes we see emerging into 2025 is an expansion in Biotechnology and a bullish backdrop for certain biotechnology stocks.Â
While the...
2025 Stock Market Outlook: Bulls Try For 3 In A Row
Equities were riding high in November, thanks to the post-election rally following Donald Trump’s win and a decent earnings season. What was more encouraging...
Long Bonds TLT: Agony and EcstasyÂ
Today, the Chairman of the Federal Reserve, Jerome Powell spoke.
Here are some highlights:
U.S. BUDGET IS ON AN UNSUSTAINABLE PATH; REVENUE AND SPENDING NEED TO...
2025 S&P 500 Price Targets Rise On Strong Earnings Trends
The Q3 2024 reporting season was, by one measure, the best in three years
Optimism abounds across Wall Street research desks as year-end 2025 S&P...